In Brief: Glaxo Wellcome's Ceftin
Executive Summary
Glaxo Wellcome's Ceftin: Cefuroxime approved Dec. 6 for treatment of penicillinase-producing Neisseria gonorrhoeae, a type of gonorrhea that is resistant to penicillin. Ceftin was also approved for rectal gonorrhea in females for non-penicillinase-producing Neisseria gonorrhoeae...